July 11 (Reuters) - Dimerix Ltd DXB.AX :
* Seeks trading halt pending announcement of results from its phase 2 trial of DMX-200 in patients with chronic kidney disease Source text for Eikon: Further company coverage: DXB.AX
July 11 (Reuters) - Dimerix Ltd DXB.AX :
* Seeks trading halt pending announcement of results from its phase 2 trial of DMX-200 in patients with chronic kidney disease Source text for Eikon: Further company coverage: DXB.AX